President Donald Trump’s new tariffs on pharmaceutical imports will not apply to countries with negotiated agreements with the US that contain provisions on drugs, according to a White House official, delivering promised relief to economies including the European Union and Japan.
Duties on pharmaceuticals from the EU will be capped at 15% per the terms of its framework deal, the official said Friday. Japanese drugs will also be charged the rate spelled out in its pact, the official added. The US-Japan joint statement says American tariff rates on Japanese drugs and semiconductors should not exceed those applied to others, including the EU.
AloJapan.com